These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 1757025

  • 1. [Absence of cataractogenic effect of lovastatin (Mevinacor) so far].
    Ulbig M, Schneider T.
    Fortschr Ophthalmol; 1991; 88(5):431-3. PubMed ID: 1757025
    [Abstract] [Full Text] [Related]

  • 2. Ocular side effects of the lipid-lowering drug simvastatin? A one year follow-up.
    Behrens-Baumann W, Morawietz A, Thiery J, Creutzfeldt C, Seidel D.
    Lens Eye Toxic Res; 1989; 6(1-2):331-7. PubMed ID: 2488025
    [Abstract] [Full Text] [Related]

  • 3. No lens changes caused by simvastatin results from a prospective drug safety study.
    Schmidt J, Schmitt C, Hockwin O.
    Lens Eye Toxic Res; 1990; 7(3-4):643-50. PubMed ID: 2100182
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of low-dose lovastatin in lowering serum cholesterol. Experience with 56 patients.
    Bates MC, Warren SG, Grubb S, Chillag S.
    Arch Intern Med; 1990 Sep; 150(9):1947-50. PubMed ID: 2393325
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lovastatin and the human lens; results of a two year study. The MSDRL Study Group.
    Chylack LT, Mantell G, Wolfe JK, Friend J, Rosner B.
    Optom Vis Sci; 1993 Nov; 70(11):937-43. PubMed ID: 8302530
    [Abstract] [Full Text] [Related]

  • 7. Influence of the HMG-CoA-reductase inhibitor lovastatin on cholesterol saturation index and nucleation time of duodenal bile.
    Nitsche R, Schlage J, Ramin V, Kirchhoff S, Fölsch UR, Creutzfeldt C, Creutzfeldt W.
    Z Gastroenterol; 1991 May; 29(5):242-5. PubMed ID: 1950033
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
    Leclercq V, Harvengt C.
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098
    [Abstract] [Full Text] [Related]

  • 12. The human lens after 48 weeks of treatment with lovastatin.
    Laties AM, Keates EU, Taylor HR, Chremos AN, Shear CL, Lippa EA, Gould AL, Hurley DP.
    N Engl J Med; 1990 Sep 06; 323(10):683-4. PubMed ID: 2385275
    [No Abstract] [Full Text] [Related]

  • 13. Traumatic cataract and other adverse events with the implantable contact lens.
    Sarikkola AU, Sen HN, Uusitalo RJ, Laatikainen L.
    J Cataract Refract Surg; 2005 Mar 06; 31(3):511-24. PubMed ID: 15811739
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB, Holmes KW, Hopkins P, Stein E, Cho M, Tate A, Johnson-Levonas AO, Kwiterovich PO.
    Pediatrics; 2005 Sep 06; 116(3):682-8. PubMed ID: 16140708
    [Abstract] [Full Text] [Related]

  • 17. [The HMG-CoA reductase inhibitors simvastatin and pravastatin. No indication for side effects in use on humans].
    Schmidt J, Schmitt C, Hockwin O.
    Fortschr Ophthalmol; 1991 Sep 06; 88(6):843-5. PubMed ID: 1794817
    [Abstract] [Full Text] [Related]

  • 18. [Lovastatin in the treatment of primary hypercholesterolemia].
    Broda G, Rywik S, Chotkowska E, Bednarek M, Kuzmińska A, Polakowska M.
    Kardiol Pol; 1991 Sep 06; 35(8):84-9. PubMed ID: 1942761
    [Abstract] [Full Text] [Related]

  • 19. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J, Oette K, Burrichter H.
    Fortschr Med; 1990 Feb 10; 108(4):71-2, 75-6. PubMed ID: 2312032
    [Abstract] [Full Text] [Related]

  • 20. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS, Illingworth DR.
    J Lab Clin Med; 1989 Nov 10; 114(5):554-62. PubMed ID: 2809398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.